Q1 2025 OrganiGram Holdings Inc Earnings Call Transcript
Key Points
- OrganiGram Holdings Inc (OGI) achieved strong momentum as Canada's largest cannabis company by market share, with significant growth in pre-rolls and vapes.
- The company completed the Motif acquisition, which is expected to yield $10 million in annualized savings within 24 months, with early synergies already being realized.
- OrganiGram expanded its national market share by 500 basis points year over year, reflecting strategic positioning in high-growth segments.
- International sales grew to $3.3 million in Q1, with expectations for continued growth throughout fiscal 2025, supported by strategic investments and partnerships.
- The company is actively pursuing global expansion opportunities, with a focus on leveraging its strong balance sheet and strategic investments for international growth.
- OrganiGram faced competitive headwinds in the Edibles category, with market share declines due to low-cost single count gummies and price compression.
- Adjusted gross margin decreased sequentially from 37% to 33%, impacted by seasonally lower volume and competitive forces in the gummy category.
- Operating expenses increased by 11% to $25.1 million, primarily due to acquisition and transaction costs related to the Motif acquisition.
- The company reported a net loss of $23 million for the quarter, compared to a net loss of $15.8 million in Q1 fiscal 2024.
- There are concerns about potential oversupply in international markets, particularly in Germany, as more licensed producers enter the space.
Good morning. My name is Krista, and I will be your conference operator today. At this time, I would like to welcome everyone to the Organigram Holdings Inc first quarter fiscal 2025 Earnings Conference Call. (Operator Instructions)
Thank you, Max Schwartz. You may begin your conference.
Thank you very much and good morning, everyone. Thanks for joining us today. As a reminder, this conference call is being recorded, and the recording will be available on Organigram's website 24 hours after today's call.
Listeners should be aware that today's call will include estimates and other forward-looking information from which the company's actual results could differ. Please review the cautionary language in our press release dated February 11, 2025, on various factors, assumptions, and risks that could cause our actual results to differ.
Further reference will be made to certain non-IFRS measures during this call, including adjusted to EBITDA, adjusted gross
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
